Sunday, January 22, 2017 11:49:31 AM
This has a long, long way to go IMO. I don't even have a pps I'm aiming for, I'm going to give this a lot of time to develop and let Dr. Jaikaria do his thing.
I'd imagine we'll eventually get some decent wall Street biotech analysts covering this, which is rare for an OTC. For that matter I highly doubt the OTC market is the final destination for this. I have not read anything, as of yet, as to what Dr. Jaikaria's plans are concerning uplisting but I personally feel it's in the cards after what happened with ImmunoCellular Therapeutics.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM